Spots Global Cancer Trial Database for metastatic malignant melanoma
Every month we try and update this database with for metastatic malignant melanoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Combination of Ipilimumab and Fotemustine for Treat Unresectable Locally Advanced or Metastatic Melanoma | NCT01654692 | Metastatic Mali... | Ipilimumab and ... | 18 Years - | Italian Network for Tumor Biotherapy | |
| Trial for Vaccine Therapy With Dendritic Cells in Patients With Metastatic Malignant Melanoma | NCT00961844 | Metastatic Mali... | Dendritic cells... Temozolomide | 18 Years - | Oslo University Hospital | |
| Inducing Systemic Immunity and Regressions in Metastatic Melanoma | NCT02350972 | Metastatic Mali... | Autologous cyto... | 21 Years - 80 Years | NYU Langone Health | |
| Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma | NCT00625768 | Metastatic Rena... Metastatic Mali... | AS1409 | 18 Years - | Antisoma Research | |
| Trial for Vaccine Therapy With Dendritic Cells in Patients With Metastatic Malignant Melanoma | NCT00961844 | Metastatic Mali... | Dendritic cells... Temozolomide | 18 Years - | Oslo University Hospital | |
| Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma | NCT02617849 | Metastatic Mali... | Pembrolizumab Carboplatin Paclitaxel | 18 Years - | Jewish General Hospital | |
| Bevacizumab vs Dacarbazine in Metastatic Melanoma | NCT01705392 | Metastatic Mali... Unresectable Ma... | Bevacizumab Propranolol Enalapril Dacarbazine | 18 Years - | Haukeland University Hospital | |
| A Combination of Ipilimumab and Fotemustine for Treat Unresectable Locally Advanced or Metastatic Melanoma | NCT01654692 | Metastatic Mali... | Ipilimumab and ... | 18 Years - | Italian Network for Tumor Biotherapy | |
| Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma | NCT00055562 | Melanoma Neoplasm Metast... | CC 5013 | 18 Years - | Celgene | |
| A Study of IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Malignant Melanoma | NCT00533702 | Metastatic Mali... | IMC-1121B (ramu... Dacarbazine | 18 Years - | Eli Lilly and Company | |
| Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma | NCT00625768 | Metastatic Rena... Metastatic Mali... | AS1409 | 18 Years - | Antisoma Research | |
| Clinical Study of Previously Untreated Patients With Malignant Melanoma | NCT00232726 | Malignant Melan... Neoplasm Metast... | CP-4055 (ELACYT... | 18 Years - | Clavis Pharma | |
| Inducing Systemic Immunity and Regressions in Metastatic Melanoma | NCT02350972 | Metastatic Mali... | Autologous cyto... | 21 Years - 80 Years | NYU Langone Health | |
| Temodar and Sutent as Therapy for Melanoma | NCT00304200 | Metastatic Mali... | Temozolomide an... | 18 Years - | Northern California Melanoma Center | |
| Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma | NCT02617849 | Metastatic Mali... | Pembrolizumab Carboplatin Paclitaxel | 18 Years - | Jewish General Hospital | |
| Bevacizumab vs Dacarbazine in Metastatic Melanoma | NCT01705392 | Metastatic Mali... Unresectable Ma... | Bevacizumab Propranolol Enalapril Dacarbazine | 18 Years - | Haukeland University Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
